Crizanlizumab: A CRITICAL Drug During a CRITICAL Time?
Standard
Crizanlizumab: A CRITICAL Drug During a CRITICAL Time? / Gue, Ying X; Pula, Giordano; Lip, Gregory Y H.
In: JACC-BASIC TRANSL SC, Vol. 6, No. 12, 12.2021, p. 946-947.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Harvard
Gue, YX, Pula, G & Lip, GYH 2021, 'Crizanlizumab: A CRITICAL Drug During a CRITICAL Time?', JACC-BASIC TRANSL SC, vol. 6, no. 12, pp. 946-947. https://doi.org/10.1016/j.jacbts.2021.10.013
APA
Gue, Y. X., Pula, G., & Lip, G. Y. H. (2021). Crizanlizumab: A CRITICAL Drug During a CRITICAL Time? JACC-BASIC TRANSL SC, 6(12), 946-947. https://doi.org/10.1016/j.jacbts.2021.10.013
Vancouver
Gue YX, Pula G, Lip GYH. Crizanlizumab: A CRITICAL Drug During a CRITICAL Time? JACC-BASIC TRANSL SC. 2021 Dec;6(12):946-947. https://doi.org/10.1016/j.jacbts.2021.10.013
Bibtex
@article{7acfcd250dd04b6f825b3313bc0a2272,
title = "Crizanlizumab: A CRITICAL Drug During a CRITICAL Time?",
author = "Gue, {Ying X} and Giordano Pula and Lip, {Gregory Y H}",
year = "2021",
month = dec,
doi = "10.1016/j.jacbts.2021.10.013",
language = "English",
volume = "6",
pages = "946--947",
journal = "JACC-BASIC TRANSL SC",
issn = "2452-302X",
publisher = "Elsevier Inc.",
number = "12",
}
RIS
TY - JOUR
T1 - Crizanlizumab: A CRITICAL Drug During a CRITICAL Time?
AU - Gue, Ying X
AU - Pula, Giordano
AU - Lip, Gregory Y H
PY - 2021/12
Y1 - 2021/12
U2 - 10.1016/j.jacbts.2021.10.013
DO - 10.1016/j.jacbts.2021.10.013
M3 - Other (editorial matter etc.)
C2 - 35024499
VL - 6
SP - 946
EP - 947
JO - JACC-BASIC TRANSL SC
JF - JACC-BASIC TRANSL SC
SN - 2452-302X
IS - 12
ER -
